Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 1:20 AM
NCT ID:
NCT00956293
Eligibility Criteria:
Inclusion criteria:
* Patients receiving a primary kidney from a donor aged \> 65 years
* In the Eurotransplant Senior Program
* Recipients of de novo cadaveric kidney transplants
Exclusion criteria:
* Multi-organ recipients (e.g., kidney and pancreas)
* Patients receiving a kidney from a non-heart beating donor
* Patients who are recipients of A-B-O incompatible transplants
* Patients with already existing antibodies against the HLA-type of the receiving transplant
* Patients who have received an investigational immunosuppressive drug within four weeks prior to study entry (Baseline visit 1)
* Patients with thrombocytopenia, with an absolute neutrophil count of \< 1,500/mm³ or leucopenia or hemoglobin \< 6 g/dL
* Patients who are HIV, HCV RNA, or Hepatitis B surface antigen positive
* Evidence of severe liver disease
* Females at randomization who will be not considered post-menopausal
Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT00956293
Study Brief:
Protocol Section:
NCT00956293